APPLIED CLINICAL TRIALS Issue Alert Having trouble viewing this email? Click here
Web Version | View Digital Edition | Subscribe
In our October issue:

FEATURED

 The State of Outsourcing: Key Benchmarks
Dennis Salotti
The Avoca Group's latest industry research survey on clinical outsourcing spend and the trends driving model selection also examines the key relationship health indicators for outsourcing–as well as other influential cohorts such as sponsor company size and respondent length of experience.

Operational Complexity in Advanced Therapies
Erin Finot
Advanced therapies (ATs) such as cell and gene therapy and tissue engineering represent a groundbreaking force in medicine and research, but as their technology and manufacturing processes evolve, there are three key clinical trial operational challenges to address unique to these products.

Eliminating Patient 'Disruption'
Rebecca Kush, John Potthoff
Most agree that new approaches to healthcare and clinical research are critical necessities in advancing pharmaceutical innovation. However, as this article explores, there are strategies that should be taken to eliminate this disruption for patients and other stakeholders–and smooth the path toward better participation.


NEWS
Washington Report: Jill Wechsler on the data-integrity enforcement climate in wake of recent high-profile lapse.

EU Report: Peter O'Donnell looks at the fight brewing in the UK over drug prices and future innovation.

Q&A: Behind new science, emerging biopharma company presses on against the rough tide of pursuing therapies for Alzheimer's.

CLOSING THOUGHT
Patient Experience & Drug Development
Irfan Khan
How one notable project is signaling a frame shift in using the patient voice to guide design thinking for technologies in clinical research.
View the digital Issue
image
 
BLOGS
3 Critical Challenges: Fulfilling the Promise of Precision Oncology
Pharma Companies Use AI to Advance Drug Development
Who’s Going to be Disrupted by Shifts in European Health Strategy?
WEBCAST
Will Decentralized Trials Compound Patient and Data Quality Risks?
Learn about the perceived benefits of conducting decentralized clinical trials; the perceived impact of DCTs on sites, staff roles, and patients; and the additional quality management elements required to mitigate patient and data quality risks resulting from these kinds of trials.

If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lhenderson@mmhgroup.com

Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.

Click here to contact the Applied Clinical Trials sales team.
Twitter LinkedIn